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ABSTRACT 18 
Our objective was to investigate clinical progression, presence of parasites and DNAs, parasite 19 
loads, and histological alterations in BALB/c mice and Syrian golden hamsters after intraperitoneal 20 
inoculation with Leishmania (Mundinia) martiniquensis promastigotes with a goal to choosing an 21 
appropriate animal model for visceral leishmaniasis. Infections were monitored for 16 weeks. Infected 22 
BALB/c mice were asymptomatic during the infection course. Parasite DNAs were detected in the liver at 23 
week 8 of infection, followed by clearance in most animals at week 16, whereas in the spleen parasite 24 
DNAs were detected until week 16. These results are correlated to those obtained measuring parasite 25 
loads in both organs. No parasite DNA and no alteration in the bone marrow were observed indicating 26 
that no dissemination occurred. These results suggest the control of visceralization of L. martiniquensis 27 
by BALB/c mice. In hamsters, weight loss, cachexia and fatigue were observed after week 11. 28 




by week 16. Parasite loads correlated with those from the presence of parasites and DNAs in the 30 
examined tissues. Alterations in the liver with nuclear destruction and cytoplasmic degeneration of 31 
infected hepatocytes, presence of inflammatory infiltrates, necrosis of hepatocytes and changes in splenic 32 
architecture and reduction and deformation of white pulp in the spleen were noted. These results indicate 33 
a chronic form of visceral leishmaniasis indicating that the hamster is a suitable animal model for the 34 
study of pathological features of chronic visceral leishmaniasis caused by L. martiniquensis. 35 
 36 




Leishmaniasis is an infectious disease caused by protozoan parasites in the genus Leishmania and occurs 41 
in many tropical and sub-tropical regions of the world. Visceral leishmaniasis is one of clinical 42 
manifestations considered as the most severe, and frequently causes death if left untreated. The two main 43 
species responsible for symptomatic leishmaniasis-attributed fatalities are L. donovani and L. infantum. 44 
Other forms of leishmaniasis include cutaneous and mucocutaneous leishmaniasis (WHO 2019). 45 
Various animal models have been used to elucidate pathogenesis, disease progression, drug 46 
treatment and immune responses to visceral leishmaniasis (Loría-Cervera and Andrade-Narváez 2014). 47 
Although several animals such as mice, hamsters, dogs, and non-human primates have been used in the 48 
study of leishmaniasis, the most widely used experimental models of visceral leishmaniasis are BALB/c 49 
mice and Syrian golden hamsters (Nieto et al. 2011). 50 
Murine models are popular and widely used in several fields of biomedical research, including the 51 
study of visceral leishmaniasis, because of the large collection of inbred strains and ability to create 52 
transgenic animals (Nieto et al. 2011; Johnson 2012). Mice have been proved as a useful model animal to 53 
investigate and characterize immune mechanisms/responses and host factors that influence Leishmania 54 
infection, identify genes involved in infection, and also predict the functional role of those genes (Nieto et 55 
al. 2011; Ong et al. 2020). However, the clinical course of visceral leishmaniasis in BALB/c mice 56 
depends on several factors including Leishmania species, inoculum size, and inoculation route (Carrion et 57 




The Syrian golden hamster is highly susceptible to L. donovani, and L. infantum, and the 59 
clinicopathological features of the hamster model of visceral leishmaniasis closely mimic the human form 60 
of the disease. The infection presents with increasing visceral parasite burden, progressive cachexia, 61 
hepatosplenomegaly, pancytopenia, hypergammaglobulinemia and ultimately death (Loría-Cervera and 62 
Andrade-Narváez 2014). In several studies, hamsters have been used as a drug treatment model in the 63 
evaluation of efficacy of new compounds for both cutaneous leishmaniasis and visceral leishmaniasis 64 
(Robledo et al. 2012; Gupta et al. 2011). 65 
In Thailand, most of leishmaniasis cases are caused by L. martiniquensis presenting as visceral and 66 
disseminated leishmaniasis (Leelayoova et al. 2017; Jariyapan et al. 2018). Animal models for the study 67 
of infectivity and pathogenesis of L. martiniquensis are needed. The clinical manifestations of an ideal 68 
animal model should resemble those occurring in humans, which present with weight loss, infection in 69 
internal organs such as liver, spleen, and bone marrow, and dissemination to the skin in the cases of 70 
immunocompromised hosts. Appropriate animal models would facilitate understanding of the biology of 71 
the parasite, clinical presentation and progression of the disease.  72 
So far, a few studies regarding animal infection of L. martiniquensis have been reported (Garin et 73 
al. 2001; Somboonpoonpol 2016; Becvar et al. 2020). Garin et al (2001) have infected BALB/c mice with 74 
two strains of a presumed monoxenous trypanosomatid isolated from humans (MHOM/MQ/92/MARl 75 
from an HIV patient and MHOM/MQ/97/MAR2 from an immunocompetent patient) that are later 76 
identified as L. martiniquensis (Desbois et al. 2014). Both strains are infective to BALB/c mice after 77 
inoculation with promastigotes subcutaneously or intravenously and able to grow and disseminate in the 78 
popliteal and mesenteric lymph nodes, liver, spleen, and brain of the mice (Garin et al. 2001). However, 79 
differences of the kinetics of parasite burdens in the organs are observed according to the infective strain. 80 
Somboonpoonpol (2016) has revealed that L. martiniquensis (MHOM/TH/2011/PG) causes visceral 81 
disease in BALB/c mice when inoculated via intravenous and intraperitoneal routes, based on the 82 
presence of amastigotes and genomic DNA of the parasite in target organs. In another study, guinea pigs 83 
(Cavia porcellus) have been infected with L. martiniquensis (MHOM/MQ/1992/MAR1 and 84 
MHOM/TH/2011/CU1). The infected animals develop only temporary erythema lesion at the site of 85 
inoculation and no infection to sand flies (Lutzomyia migonei) is observed indicating that guinea pigs are 86 




previous experience (Handman 2001), different strains of L. martiniquensis might be expected to cause 88 
different progression of visceral disease. Therefore, the current study was performed using a different 89 
strain of L. martiniquensis (MHOM/TH/2013/LSCM3) and to explore the possible use of hamsters as an 90 
alternative model. Infection and clinical progression of the disease was studied including presence of 91 
parasites and DNAs, parasite loads, and histological alterations of liver and spleen in both BALB/c mice 92 
and Syrian golden hamsters. The experimental data obtained from this study will help in determining an 93 
appropriate model for pathological study of visceral leishmaniasis caused by L. martiniquensis. 94 
 95 
Materials and Methods 96 
Animals and ethics statement 97 
Male 8-10 week old BALB/c mice (Mus musculus) were purchased from Nomura Siam International Co., 98 
Ltd, Bangkok, Thailand. Male 8-10 week old Syrian golden hamsters (Mesocricetus auratus) were 99 
obtained from the animal house unit (in-house breeding) of the Faculty of Medicine, Chiang Mai 100 
University. All procedures performed on experimentally infected animals were reviewed and approved by 101 
the Ethics Committee on Animal Use of the Laboratory Animal Center, Chiang Mai University (Protocol 102 
number 2561/MC-0008). 103 
 104 
Parasites 105 
L. martiniquensis (MHOM/TH/2013/LSCM3) was used in this study (Chiewchanvit et al. 2015). 106 
Parasites were maintained in BALB/c mice for use in experimental infections as described below. 107 
 108 
Preparation of promastigotes to infect animals 109 
L. martiniquensis parasites used for experimental infections were isolated from the spleens of BALB/c 110 
mice previously inoculated intraperitoneally with L. martiniquensis promastigotes and maintained for 16 111 
weeks. Briefly, an infected mouse spleen was collected aseptically and placed in a small volume of sterile 112 
phosphate buffer saline (PBS). The spleen was minced and strained using a cell strainer (SPL Life 113 
Sciences Co., Ltd., Gyeonggi-do, Korea) using aseptic techniques. The suspension was washed by 114 
centrifugation at 26 °C, 1,500 ×g for 10 min, the cell pellet resuspended in Schneider’s insect medium 115 




sulfate and cultured in the same medium at 26 °C without shaking. After 3-5 days of cultivation, 117 
promastigotes observed in the culture were subpassaged into RPMI-1640 medium supplemented with 118 
20% FBS, pH 5.5, 25 μg/mL gentamicin sulfate to stimulate metacyclogenesis (Zakai et al. 1998). The 119 
resulting stationary phase promastigotes at day 5 of cultivation were used to infect animals.  120 
 121 
Experimental infections 122 
Eighteen BALB/c mice and 18 hamsters were used in this study. In each experiment, six animals were 123 
used as a control group and injected intraperitoneally with PBS. Twelve animals were intraperitoneally 124 
injected with 2×107 promastigotes of L. martiniquensis resuspended in 100 µl of PBS. The evolution of L. 125 
martiniquensis infection in BALB/c mice and hamsters was monitored weekly for clinical signs (weight 126 
loss, cachexia, fatigue, ascites, scabs or skin lesions, hepatomegaly, and splenomegaly) and their body 127 
weight recorded using a balance (Sartorious TE313S Talent Analytical Balance, Sartorius AG, 128 
Goettingen, Germany). At 8 and 16 weeks post infection, three animals from each control group and six 129 
animals from each infected group were sacrificed using isoflurane anesthesia. In each animal, the liver, 130 
spleen, and bone marrow were removed separately under sterile conditions. The liver and spleen were 131 
examined macroscopically and appearance recorded using a digital camera. Then, the liver and spleen 132 
samples were weighed and cut into several portions to examine for parasites using impression smears, 133 
culture, and histological analysis, and for detection of parasite DNAs using a PCR method (below). For 134 
bone marrow samples, only impression smears and PCR were performed. 135 
 136 
Tissue impression smears 137 
Tissue samples of the liver, spleen, and bone marrow from infected BALB/c mice and hamsters (8 and 16 138 
weeks post infection) were smeared on glass slides. After air-drying, the smears were fixed with absolute 139 
methanol and stained with 5% (v/v) Giemsa’s solution for 30 min. The stained smears were examined 140 
under a light microscope (Olympus America Inc., Center Valley, PA, USA) for amastigotes of L. 141 
martiniquensis. 142 
 143 




Parasite loads in the liver and spleen of BALB/c mice and hamsters at 8 and 16 weeks post infection were 145 
quantified by limiting dilution assay (Buffet et al. 1995). Briefly, a piece of the infected liver or spleen 146 
was weighed on a precision balance and then minced in Schneider’s insect medium supplemented with 147 
10% FBS and 25 μg/mL gentamicin sulfate. The homogenates were strained using a cell strainer and 148 
washed in the medium by centrifugation at 26 °C, 1,500 ×g for 10 min. The supernatant medium was 149 
discarded. The pellet was resuspended in the same medium and dispensed in a 96 well microtiter culture 150 
plate (Nunc, Roskilde, Denmark). The suspension was five-fold serially diluted in the medium and 151 
incubated at 26 °C. The presence or absence of promastigotes in each well, which was examined daily for 152 
14 days with an inverted light microscope (Olympus America Inc., Center Valley, PA, USA), was 153 
recorded. The parasite load was determined from mean of reciprocal positive titers (the last dilution 154 
containing promastigotes) divided by weight of homogenized cross section and calculated as the number 155 
of parasites per gram of organ. 156 
 157 
Histological analysis 158 
The liver and spleen of uninfected and infected BALB/c mice and hamsters at 8 and 16 weeks post 159 
infection were used for the histological analysis. Tissue samples of these organs were fixed in 10% 160 
buffered formalin solution and processed for embedding in paraffin. Tissue sections (5 mm) were cut 161 
using a microtome (Zeiss Hyrax M25, Oberkochen, Germany) and stained with Hematoxylin-Eosin (HE). 162 
The stained sections were examined under a light microscope (Olympus America Inc., Center Valley, PA, 163 
USA) to analyze histological alterations, cellular inflammatory infiltrates, and the presence of L. 164 
martiniquensis amastigotes in the organ tissues. 165 
 166 
Detection of L. martiniquensis DNA by PCR 167 
Total genomic DNA was extracted from tissues of the liver, spleen, and bone marrow of 8 and 16 weeks-168 
infected BALB/c mice and hamsters using a genomic DNA purification kit (Thermo Fisher Scientific 169 
Inc., Waltham, MA, USA) according to the manufacturer’s instructions. Parasite DNA was detected by 170 
amplification of Leishmania rRNA ITS-1 using the LeF/LeR primers (Spanakos et al. 2008). The PCR 171 
reaction mixture contained template DNA, 1×PCR reaction buffer (Invitrogen, Carlsbad, CA, USA), 4 172 




0.8 mM of each dNTPs (Invitrogen, Carlsbad, CA, USA), and 1U of Taq DNA polymerase (Invitrogen, 174 
Carlsbad, CA, USA). Amplification was performed in TPersonal Combi Thermocycler (Biometra, 175 
Göttingen, Germany) using a step of initial denaturation at 94 °C for 5 min, followed by 35 cycles of 176 
denaturation at 94 °C for 1 min, annealing at 65 °C for 1 min, extension at 72 °C for 2 min, and a final 177 
extension step at 72 °C for 5 min. Amplified products were run on 1.2% agarose gels (Amresco, Atlanta, 178 
GA, USA) containing ethidium bromide. 179 
 180 
Statistical analysis 181 
Statistical analysis was performed using GraphPad Prism 6.0 program (Graphpad Software Inc., San 182 
Diego, CA, USA). Animal weight, organ weight, and parasite loads were expressed as mean ± standard 183 
deviation (SD) of six animals per group. Comparisons of animal weight between groups during infection 184 
were analyzed by two-way analysis of variance (ANOVA), followed by the Bonferroni’s multiple 185 
comparison tests. The difference between weight of uninfected and infected organs was analyzed by 186 
Student’s t-test. Comparisons of parasite loads between groups during infection were analyzed by two-187 
way ANOVA, followed by the Tukey’s multiple comparison tests. Differences were considered 188 
significant when p values were ≤ 0.05. 189 
 190 
Results 191 
Clinical progression of L. martiniquensis infection in BALB/c mice and Syrian golden hamsters 192 
Mice and hamsters were experimentally infected with L. martiniquensis promastigotes. After Leishmania 193 
infection, all infected groups reached the study endpoint at 8 and 16 weeks. Over the period of 194 
observation, infected BALB/c mice gained their body weight over time and did not lose weight compared 195 
to the uninfected group (Fig. 1a). In contrast, infected hamsters only sustained their body weight after 196 
infection and began to lose their body weight from 11 weeks post infection onwards. A significant change 197 
in the body weight of infected hamsters compared to uninfected controls was observed from week 13 to 198 
week 16 (Fig. 1a). No statistically significant differences in the weights of liver and spleen of both 16 199 
weeks-infected BALB/c mice and hamsters compared to uninfected groups were found (Fig. 1b). In 200 
infected BALB/c mice, no clinical signs of the disease were found throughout the experiment. However, 201 




fatigue, but no ascites, scabs or skin lesions were seen. At necropsy, no changes in colors of the livers and 203 
spleens of infected animals were observed (Fig. 1c). No fibrosis was found in any organs. No 204 
hepatomegaly and splenomegaly was observed in any infected animals (Fig. 1c). 205 
 206 
Presence of L. martiniquensis parasites and DNAs in organ tissues of BALB/c mice and Syrian 207 
golden hamsters 208 
The liver, spleen, and bone marrow of all infected animals were removed and investigated for Leishmania 209 
infection. At 8 weeks post infection, no parasites were observed in any impression smears of the liver, 210 
spleen, and bone marrow samples of any infected mice or hamsters (data not shown). In contrast, by 16 211 
weeks tissue impression smears of the liver, spleen, and bone marrow of infected hamsters presented 212 
numerous intracellular and free amastigotes (Fig. 2d-f), whereas no parasites were seen in tissue smears 213 
from the mice at this time point (Fig. 2a-c).  214 
Detection of L. martiniquensis DNA using the PCR method was performed on all tissue samples 215 
of both infected animals to confirm the impression smear results. PCR results showed that parasite DNAs 216 
were detected in the liver and spleen of BALB/c mice, which were negative by impression smears (Fig. 217 
3). In the BALB/c liver tissues, parasite DNAs were detected in five of six infected mice at 8 weeks post 218 
infection and one of six infected mice at 16 weeks post infection. For the spleen tissues, parasite DNAs 219 
were detected in four of six infected mice at 8 weeks post infection and all infected mice at 16 weeks post 220 
infection (Fig. 3). In hamsters infected with L. martiniquensis, parasite DNAs were detected in tissues of 221 
the liver and spleen of all infected hamsters at 8 and 16 weeks post infection. For the bone marrow 222 
samples, parasite DNAs were only detected at 16 weeks post infection in infected hamsters (Fig. 3). 223 
 224 
Parasite loads in BALB/c mice and hamsters infected with L. martiniquensis 225 
Parasite loads in infected organs were quantified using a limiting dilution assay. At 8 weeks post 226 
infection, similar levels of infection were observed in the livers of BALB/c mice (~1×103 parasites/gram 227 
of organ) and hamsters (~5×103 parasites/gram of organ) that were not statistically significantly different 228 
(Fig. 4a). However, at 16 weeks post infection, a statistically significant increase of parasite load in the 229 




BALB/c mice (~5×102 parasites/gram of organ) did not significantly increase compared to those at 8 231 
weeks post infection (Fig. 4a).  232 
In the spleen, no statistically significant differences in parasite loads were observed between 8 and 233 
16 weeks post infection in BALB/c mice. However, as in the liver, at 16 weeks post infection, parasite 234 
load in the spleens of hamsters (1×107 parasites/gram of organ) was significantly greater than those at 8 235 
weeks of infection (~5×104 parasites/gram of organ) and at 16 weeks post infection in BALB/c mice 236 
(~1×104 parasites/gram of organ) (Fig. 4b). 237 
 238 
Histological alterations in the liver and spleen of infected animals 239 
In infected BALB/c mice no pathological changes in liver and spleen sections after L. martiniquensis 240 
infection at 8 and 16 weeks were seen (data not shown). Similar results were seen in hamsters at 8 weeks 241 
post infection (data not shown). However, for hamsters, alterations of the infected liver were seen at 16 242 
weeks post infection with large areas of necrosis (Fig. 5b). Compared to normal liver tissue of the 243 
uninfected hamsters (Fig. 5a) cellular infiltrates of macrophages and lymphocytes were observed in the 244 
perivascular region (Fig. 5b). Also, compared to normal hepatocytes of the uninfected liver (Fig. 5c) 245 
nuclear destruction and cytoplasmic degeneration of the infected hepatocytes and the presence of 246 
amastigotes of L. martiniquensis were found in the infected tissue (Fig. 5d). Changes in splenic 247 
architecture were presented in the infected spleen. Reduction and deformation of white pulp compared to 248 
those of uninfected control were noted (Fig. 5e and 5f). Compared to the normal white pulp of the 249 
uninfected spleen (Fig. 1g), in the infected spleen, clusters of macrophages and numerous amastigotes 250 
were found (Fig. 5h). 251 
 252 
Discussion 253 
Experimental infections with L. martiniquensis in BALB/c mice and Syrian golden hamsters were 254 
performed to investigate an appropriate animal model for this Leishmania species. Mice and hamsters 255 
were injected intraperitoneally with promastigotes of L. martiniquensis and then monitored for 16 weeks. 256 
In this study, the infected BALB/c mice were clinically asymptomatic, whereas the infected hamsters 257 
developed symptomatic infection after 11 weeks post infection, presenting with weight loss, cachexia and 258 




splenomegaly are common in visceral leishmaniasis, however, most models of murine infection exhibit 260 
the subclinical or asymptomatic form of visceral leishmaniasis (Aslan et al. 2013; Gomes-Silva et al. 261 
2013; Martín-Martín et al. 2015; McCall et al. 2013). The splenomegaly could appear in BALB/c mice 262 
depending on the inoculum size (de Melo et al. 2020). Hamsters infected with L. infantum present 263 
splenomegaly after 3 months post-infection being more evident at 6 and 9 months after the infection 264 
(Moreira et al. 2016). 265 
Although the macroscopic examinations of the liver and spleen of infected hamsters were normal, 266 
numerous amastigotes were found in tissue impression smears of all examined organs of the infected 267 
hamsters at week16 of infection. These results indicate that L. martiniquensis parasites were able to infect 268 
the liver and spleen of hamsters and disseminated to their bone marrow, which correlated with the 269 
severity of infection. However, in BALB/c mice, amastigotes were not found in the tissue impression 270 
smears examined, but parasite DNAs were detected in the liver and spleen tissues, suggesting that the 271 
PCR method was more appropriate for detection of these low numbers of amastigotes in the organ tissues 272 
than the microscopic method. PCR based methods have been used to detect Leishmania parasite in 273 
several studies as they have provided high sensitivity, accuracy, and reproducibility (Solotra et al. 2001; 274 
Pothirat et al. 2014; Chiewchanvit et al. 2015; Ranasinghe et al. 2015; Montalvo et al. 2017; Medkour et 275 
al. 2020).  276 
L. martiniquensis DNAs were detected in tissues of mice and hamsters at various points. For 277 
BALB/c mice, parasite DNAs were detected in the liver at week 8 of infection, followed by nearly 278 
clearance of parasites in week 16, whereas in the spleen parasite DNAs were detected in all animals at 16 279 
weeks of infection. No parasite DNA was detected in the bone marrow of mice at any time point 280 
indicating that no dissemination of parasites to the bone marrow occurred. These results suggest the 281 
control of visceralization of L. martiniquensis in BALB/c mice. Another reason might be due to the 282 
period of the infection course in this study. Evaluation of parasite persistence and visceralization in 283 
BALB/c mice might need a longer infection course.  284 
Garin et al (2001) have monitored the infection of two strains of a presumed lower trypanosomatid 285 
(later identified as L. martiniquensis by Desbois et al (2014)) isolated from an HIV-infected patient 286 
(MHOM/MQ/92/MARl) and an immunocompetent patient (MHOM/MQ/97/MAR2) in BALB/c mice for 287 




observed in liver, spleen, foot pad, popliteal, and mesenteric lymph nodes in mice infected with 289 
MHOM/MQ/92/MARl promastigotes via subcutaneous inoculation. In mice infected with 290 
MHOM/MQ/92/MARl promastigotes via intravenous inoculation, parasites are found in liver, spleen, 291 
mesenteric lymph node, and brain. For mice infected with MHOM/MQ/92/MAR2 parasites via 292 
subcutaneous inoculation, at day 150, parasites are found only in foot pad and popliteal lymph node but 293 
via intravenous inoculation parasites are observed in liver, spleen, and mesenteric lymph node. At all time 294 
point of infection, no parasites are observed in liver and spleen of BALB/c mice infected with 295 
MHOM/MQ/92/MAR2 parasites via subcutaneous inoculation, whereas mice infected with the same 296 
strain via intravenous inoculation, parasites are observed in both organs. In our study, the BALB/c mice 297 
were intraperitoneally injected with 2×107 L. martiniquensis (MHOM/TH/2013/LSCM3) promastigotes 298 
and parasites were detected in liver and spleen at all time point of the infection. Recently, the study of the 299 
infection of L. martiniquensis (MHOM/TH/2011/PG) in BALB/c mice has shown that, after intravenous 300 
inoculation and intraperitoneal inoculation with 5×106 promastigotes, parasite DNAs are detected in the 301 
bone marrow at 16 weeks post-infection (Somboonpoonpol 2016). In the present study, no L. 302 
martiniquensis (MHOM/TH/2013/LSCM3) DNAs were found in bone marrow at the same time point of 303 
the infection. These results suggest that several factors such as parasite strain, inoculum size and 304 
inoculation route influence the outcome of visceral leishmaniasis caused by L. martiniquensis in BALB/c 305 
mice. 306 
From experimental data on L. infantum infection in BALB/c mice reviewed by Loeuillet et al 307 
(2016), elimination of parasites in the liver and their persistence in the spleen involves organ-specific 308 
immune responses. In the early stage of infection, L. infantum promastigotes are rapidly cleared (more 309 
than 95%) from the circulation of infected BALB/c mice via phagocytosis by marginal zone macrophages 310 
in spleen. In the liver, L. infantum promastigotes invade the resident macrophages, Kupffer cells and 311 
dendritic cells, becoming amastigotes and replicating. In the first two weeks, in liver, TGFβ (macrophage-312 
inhibitory cytokines) levels are elevated. TGFβ produced by cells of the spleen red pulp may contribute to 313 
the establishment of infection and parasite replication. In addition, a Th1 immune response inducing 314 
macrophages to synthesize leishmanicidal molecules, such as nitric oxide (NO) is ineffective. Both 315 
elevated TGFβ levels and ineffective Th1 response allow uncontrolled parasite growth. In the spleen, in 316 




of producing IFNγ and IL2 (macrophage-activating cytokines) that promote NO synthesis. After the first 318 
4 weeks of infection, the immune cells recover their capacity to produce IFNγ, thus promoting 319 
leishmanicidal activity of the macrophages with NO synthesis and control of granuloma formation 320 
(parasitized Kupffer cells) in the liver. Thus, parasite burden reduces ultimately. In synergy with IFNγ, 321 
IL17A also contributes to macrophage activation with NO production, leading to parasite clearance. In 322 
liver, infection is resolved after 8 weeks of infection. However, in the spleen, infection is maintained 323 
during the entire visceral leishmaniasis course. L. infantum parasite persistence may be due to sustained 324 
TGFβ production by CD4+ CD25+ T cells that contributes to immunosuppression (Rodrigues et al. 2009). 325 
The control of visceralization of L. martiniquensis infection in BALB/c mice might use similar immune 326 
control of infection as in L. infantum.  327 
In hamsters, L. martiniquensis parasites grew and persisted in the liver, spleen, and bone marrow 328 
over the period of infection suggesting this animal is a suitable experimental model for study of 329 
pathological features of visceral leishmaniasis caused by L. martiniquensis. A possible explanation for the 330 
suitability of this experimental model might be similar to that seen in experimental studies in L. infantum 331 
and L. donovani-infected hamsters, where early production of IL10 and TGFβ and the impairment of NO 332 
synthesis in response to IFNϒ contribute to establishing of Leishmania infection and defective parasite 333 
killing (Melby et al. 2001; Nieto et al. 2011). However, more studies of cytokine production kinetics and 334 
activation of the different classes of immune cells by L. martiniquensis infection in both BALB/c mice 335 
and hamsters are required. 336 
Considering parasite load, which indicates the growth capacity of parasites in animal organs, we 337 
observed that growth of L. martiniquensis parasites was limited in the tissues of BALB/c mice. Parasite 338 
numbers had not increased in liver and spleen at 16 weeks of infection compared to 8 weeks. In contrast, 339 
in hamsters, parasites had significantly increased in number by 16 weeks of infection in both liver and 340 
spleen. These results correlate with those on the presence of parasites in tissue smears and DNAs in the 341 
examined organs. It is possible that the high parasite growth induced an inflammatory response and the 342 
resulting pathological changes observed in the organ tissues of hamsters. 343 
Hamsters infected with L. martiniquensis had significant changes in the liver and spleen tissues. 344 
Alterations in the liver with necrosis of hepatocytes appeared to be a consequence of amastigote infection. 345 




around the portal vein was similar to several studies on visceral leishmaniasis (Gomes-Silva et al. 2013; 347 
Rashidi et al. 2018). Inflammatory infiltrates indicate a chronic hepatitis due to Leishmania infection. The 348 
Kupffer cells containing parasites in their cytoplasm develop a progressive cellular swelling, nuclear 349 
degeneration and disruption of plasma membrane (González et al. 1988; Vianna et al. 2002). Infection by 350 
L. martiniquensis parasites changed the morphology of splenic pulps, and also reduction and deformation 351 
of white pulp in the spleen of infected hamsters were observed. This is similar to the data reviewed by 352 
Hermida et al (2018) that white pulp atrophy, disappearance of secondary lymphoid follicles and the 353 
marginal zone, and morphological alterations of the red and white pulps are associated with the chronic 354 
severe form of visceral leishmaniasis in dogs infected with L. infantum. 355 
In conclusion, this work examined the infection of L. martiniquensis in BALB/c mice and Syrian 356 
golden hamsters, with regard to clinical presentation, visceralization and proliferation of parasites, and 357 
histological alterations in the organ tissues. During the course of infection no clinical signs were observed 358 
in BALB/c mice. Parasite DNAs were detected in the liver at week 8 of infection, but cleared in most 359 
animals at week 16, whereas parasite DNA was detected in the spleen until week 16 of infection. These 360 
results are correlated with the results of parasite loads in the liver and spleen. No dissemination to the 361 
bone marrow occurred and no alterations in the tissues of the BALB/c mice were observed. However, 362 
extension of the period of infection up to 1 year for BALB/c mice could provide more information 363 
regarding clinical manifestations, pathological changes in tissues/organs, and biochemical/hematological 364 
alterations. For Syrian golden hamsters, weight loss, cachexia and fatigue were observed after 11 weeks 365 
of infection. L. martiniquensis parasites infected both liver and spleen and disseminated to bone marrow. 366 
Parasite loads correlated with the results of presence of parasites and DNAs in liver and spleen. At week 367 
16 of infection, hamsters infected with L. martiniquensis exhibited signficant histological alterations in 368 
the liver and spleen tissues indicating progressive visceral leishmaniasis. Therefore, the Syrian golden 369 
hamster is an appropriate animal model for study of pathological features of chronic visceral 370 
leishmaniasis caused by L. martiniquensis. 371 
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 499 
Figure captions 500 
Fig. 1 Comparative clinicopathology of L. martiniquensis infection in BALB/c and Syrian golden 501 
hamsters. a Body weights of infected mice and hamsters compared to uninfected groups over time of 502 
infection. b Liver (left bar) and spleen (right bar) weights of 16 weeks-infected mice and hamsters 503 
compared with uninfected group. Results are expressed as mean ± SD. c Macroscopic aspect of infected 504 
and uninfected animals, infected livers, and infected spleens compared to uninfected organs. Bar = 1 cm 505 
 506 
Fig. 2 Light micrographs of Giemsa-stained imprints from the liver and spleen of BALB/c mice and 507 
Syrian golden hamsters after 16 weeks post infection. a Liver, b spleen, and c bone marrow impression 508 
smears of mice. d liver, e spleen, and f bone marrow impression smears of hamsters. Arrows indicate 509 
amastigotes of L. martiniquensis. Bar: 20 μm 510 
 511 
Fig. 3 PCR amplification of L. martiniquensis DNAs in tissue samples of BALB/c mice and Syrian 512 
golden hamsters using LeF/LeR primers for Leishmania rRNA ITS-1. Tissues of animals were sampled at 513 
8 and 16 weeks post infection (w pi.). Lanes: MW, 100 bp DNA ladder; Neg, negative control - no DNA; 514 
Pos, positive control - L. martiniquensis DNA; a-f, samples from mice; g-l, samples from hamsters. BM - 515 
bone marrow 516 
 517 
Fig. 4 Parasite loads in the livers and spleens of BALB/c mice and Syrian golden hamsters infected with 518 
L. martiniquensis determined by limiting dilution assay. a Parasite load quantified from the liver of 519 




of infected mice and hamsters at 8 and 16 weeks post infection. Results are expressed as mean ± SD of 521 
six animals per group. White bar: BALB/c. Black bar: hamster. **p ≤ 0.001, ****p ≤ 0.0001 522 
 523 
Fig. 5 Histological sections of the liver and spleen of L. martiniquensis-infected hamsters compared with 524 
uninfected controls. a Normal tissue of the uninfected liver with normal cellular organization. b 525 
Mononuclear infiltrates in perivascular region and tissue alterations found in the infected liver. c Normal 526 
hepatocytes of the uninfected liver. d Degenerating hepatocytes of the infected liver showing non-527 
nucleated cells. Arrows indicate cells containing amastigotes inside. e Normal architecture of the 528 
uninfected spleen with distinction between the white and red pulp. f Deformation and reduction of the 529 
white pulp of the infected spleen. g Normal white pulp of the uninfected spleen. h Clusters of 530 
macrophages containing numerous amastigotes inside (arrows) found in the infected spleen. PV: portal 531 
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